新規登録 | ログイン | FAQ      [?] 

BioDrugs

最近発刊の雑誌の目次より: BioDrugs © Adis International
  • Pro-Angiogenic Cytokines as Cardiovascular Therapeutics: Assessing the Potential
    BioDrugs, Vol. 22, No. 4. (2008), pp. 209-222.
    by Atluri, Pavan, Woo, Y Joseph
  • Strategies Toward the Improved Oral Delivery of Insulin Nanoparticles via Gastrointestinal Uptake and Translocation
    BioDrugs, Vol. 22, No. 4. (2008), pp. 223-237.
    by Woitiski, B Camile, Carvalho, A Rui, Ribeiro, J Antonio, Neufeld, J Ronald, Veiga, Francisco
  • B-Cell-Targeted Therapy for Systemic Lupus Erythematosus: An Update
    BioDrugs, Vol. 22, No. 4. (2008), pp. 239-249.
    by Ding, Changhai, Foote, Simon, Jones, Graeme
  • Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus
    BioDrugs, Vol. 22, No. 4. (2008), pp. 251-257.
    by Vilsboll, Tina, Knop, K Filip
  • Anti-Adhesion Molecule Strategies for Crohn Disease
    BioDrugs, Vol. 22, No. 4. (2008), pp. 259-264.
    by Leung, Yvette, Panaccione, Remo
  • Autologous T-Cell Vaccination for Multiple Sclerosis: A Perspective on Progress
    BioDrugs, Vol. 22, No. 4. (2008), pp. 265-273.
    by Vandenbark, A Arthur, Abulafia-Lapid, Rivka
  • Spotlight on Lanreotide Autogel in Acromegaly
    BioDrugs, Vol. 22, No. 4. (2008), pp. 275-277.
    by Croxtall, D Jamie, Scott, J Lesley
  • Calcitonin A Drug of the Past or for the Future?: Physiologic Inhibition of Bone Resorption while Sustaining Osteoclast Numbers Improves Bone Quality
    BioDrugs, Vol. 22, No. 3. (2008), pp. 137-144.
    by Karsdal, A Morten, Henriksen, Kim, Arnold, Michel, Christiansen, Claus
  • Developing Therapeutic Immunoglobulins: European Regulatory Perspectives and Implications
    BioDrugs, Vol. 22, No. 3. (2008), pp. 145-160.
    by Kurz, Manfred
  • Peptide Inhibition of HIV-1: Current Status and Future Potential
    BioDrugs, Vol. 22, No. 3. (2008), pp. 161-175.
    by Kaushik-Basu, Neerja, Basu, Amartya, Harris, Dylan
  • Mecasermin
    BioDrugs, Vol. 22, No. 3. (2008), pp. 177-188.
    by Keating, M Gillian
  • Omalizumab: A Review of its Use in the Treatment of Allergic Asthma
    BioDrugs, Vol. 22, No. 3. (2008), pp. 189-204.
    by Plosker, L Greg, Keam, J Susan
  • Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix]: Profile Report
    BioDrugs, Vol. 22, No. 3. (2008), pp. 205-208.
    by Keam, J Susan, Harper, M Diane
  • Prostate Cancer Vaccines: Current Status and Future Potential
    BioDrugs, Vol. 22, No. 2. (2008), pp. 71-84.
    by Doehn, Christian, Bohmer, Torsten, Kausch, Ingo, Sommerauer, Martin, Jocham, Dieter
  • Cell Adhesion Antagonists: Therapeutic Potential in Asthma and Chronic Obstructive Pulmonary Disease
    BioDrugs, Vol. 22, No. 2. (2008), pp. 85-100.
    by Woodside, G Darren, Vanderslice, Peter
  • Recombinant Human Growth Hormone: Rationale for Use in the Treatment of HIV-Associated Lipodystrophy
    BioDrugs, Vol. 22, No. 2. (2008), pp. 101-112.
    by Benedini, Stefano, Terruzzi, Ileana, Lazzarin, Adriano, Luzi, Livio
  • Bevacizumab: In First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
    BioDrugs, Vol. 22, No. 2. (2008), pp. 113-120.
    by Frampton, E James, Keating, M Gillian
  • Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders
    BioDrugs, Vol. 22, No. 2. (2008), pp. 121-136.
    by Croom, F Katherine, Mccormack, L Paul
  • Convergence of Nanotechnology and Cardiovascular Medicine: Progress and Emerging Prospects
    BioDrugs, Vol. 22, No. 1. (2008), pp. 1-10.
    by Iverson, Nicole, Plourde, Nicole, Chnari, Evangelia, Nackman, B Gary, Moghe, V Prabhas
  • Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics
    BioDrugs, Vol. 22, No. 1. (2008), pp. 11-26.
    by Jazayeri, A Jalal, Carroll, J Graeme
  • Targeted Immunotherapy for Staphylococcal Infections: Focus on Anti-MSCRAMM Antibodies
    BioDrugs, Vol. 22, No. 1. (2008), pp. 27-36.
    by Otto, Michael
  • Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
    BioDrugs, Vol. 22, No. 1. (2008), pp. 37-44.
    by Kharitonenkov, Alexei, Shanafelt, B Armen
  • Vaccine Approaches to Prevent and Treat Prion Infection: Progress and Challenges
    BioDrugs, Vol. 22, No. 1. (2008), pp. 45-52.
    by Muller-Schiffmann, Andreas, Korth, Carsten
  • Ribonucleases as Novel Chemotherapeutics: The Ranpirnase Example
    BioDrugs, Vol. 22, No. 1. (2008), pp. 53-58.
    by Lee, J Eugene, Raines, T Ronald
  • Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    BioDrugs, Vol. 22, No. 1. (2008), pp. 59-69.
    by Keam, J Susan
  • Acknowledgment
    BioDrugs, Vol. 21, No. 6. (2007), pp. 343-344.
    by Adis I Limited,
  • Tumor Necrosis Factor-: A Promising Therapeutic Target for Asthma?
    BioDrugs, Vol. 21, No. 6. (2007), pp. 345-349.
    by Heffler, Enrico, Berry, Mike, Pavord, D Ian
  • Biosimilar Drugs: Concerns and Opportunities
    BioDrugs, Vol. 21, No. 6. (2007), pp. 351-356.
    by Genazzani, A Armando, Biggio, Giovanni, Achille P Caputi, , Mario Del Tacca, , Drago, Filippo, Fantozzi, Roberto, Pier L Canonico,
  • Progress and Challenges towards the Development of Malaria Vaccines
    BioDrugs, Vol. 21, No. 6. (2007), pp. 357-373.
    by Tetteh, KA Kevin, Polley, D Spencer
  • Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
    BioDrugs, Vol. 21, No. 6. (2007), pp. 375-385.
    by Parkinson, E Kenneth, Minty, Fay
  • Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation
    BioDrugs, Vol. 21, No. 6. (2007), pp. 387-401.
    by Jurk, Marion, Vollmer, Jorg
  • The Role of Anti-IgE Therapy in Combination with Allergen Specific Immunotherapy for Seasonal Allergic Rhinitis
    BioDrugs, Vol. 21, No. 6. (2007), pp. 403-410.
    by Stock, Philippe, Rolinck-Werninghaus, Claudia, Wahn, Ulrich, Hamelmann, Eckard
  • Cutting-Edge Apoptosis-Based Therapeutics: A Panacea for Cancer?
    BioDrugs, Vol. 21, No. 5. (2007), pp. 273-297.
    by Fischer, Ute, Janssen, Katja, Schulze-Osthoff, Klaus
  • Selective Targeting of Cancer Stem Cells: A New Concept in Cancer Therapeutics
    BioDrugs, Vol. 21, No. 5. (2007), pp. 299-310.
    by Korkaya, Hasan, Wicha, S Max
  • Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Therapeutics: Current Status
    BioDrugs, Vol. 21, No. 5. (2007), pp. 311-321.
    by Kowalski, J Timothy, Sasikumar, Thavalakulamgar
  • Autologous Conditioned Serum in the Treatment of Orthopedic Diseases: The Orthokine Therapy
    BioDrugs, Vol. 21, No. 5. (2007), pp. 323-332.
    by Wehling, Peter, Moser, Carsten, Frisbie, David, Mcilwraith, C Wayne, Kawcak, E Christopher, Krauspe, Ruediger, Reinecke, A Julio
  • Rituximab: In Rheumatoid Arthritis
    BioDrugs, Vol. 21, No. 5. (2007), pp. 333-341.
    by Frampton, E James, Scott, J Lesley
  • Rituximab in Rheumatoid Arthritis: A Viewpoint by Paul Emery
    BioDrugs, Vol. 21, No. 5. (2007), pp. 342-342.
    by Emery, Paul
  • Rituximab in Rheumatoid Arthritis: A Viewpoint by Maxime Dougados
    BioDrugs, Vol. 21, No. 5. (2007), pp. 342-342.
    by Dougados, Maxime
  • Targeting Angiogenesis in Advanced Breast Cancer
    BioDrugs, Vol. 21, No. 4. (2007), pp. 209-214.
    by Zelnak, B Amelia, Oregan, M Ruth
  • Molecularly Targeted Therapeutics for Breast Cancer
    BioDrugs, Vol. 21, No. 4. (2007), pp. 215-224.
    by Hussain, A Syed, Palmer, H Daniel, Spooner, David, Rea, W Daniel
  • Targeting Mitosis for Anti-Cancer Therapy
    BioDrugs, Vol. 21, No. 4. (2007), pp. 225-233.
    by Sudakin, Valery, Yen, J Timothy
  • Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?
    BioDrugs, Vol. 21, No. 4. (2007), pp. 235-243.
    by Grunweller, Arnold, Hartmann, K Roland
  • Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    BioDrugs, Vol. 21, No. 4. (2007), pp. 245-257.
    by Emerson, M Vaughn, Lauer, K Andreas
  • Biotechnology and the Treatment of Addictive Disorders: New Opportunities
    BioDrugs, Vol. 21, No. 4. (2007), pp. 259-267.
    by Elkashef, Ahmed, Biswas, Jamie, Acri, B Jane, Vocci, Frank
  • Spotlight on Agalsidase Beta in Fabry Disease
    BioDrugs, Vol. 21, No. 4. (2007), pp. 269-271.
    by Keating, M Gillian, Simpson, Dene
  • Tacrolimus in Heart Transplant Recipients: An Overview
    BioDrugs, Vol. 21, No. 3. (2007), pp. 139-143.
    by Patel, K Jignesh, Kobashigawa, A Jon
  • Epitope Mapping: The First Step in Developing Epitope-Based Vaccines
    BioDrugs, Vol. 21, No. 3. (2007), pp. 145-156.
    by Gershoni, M Jonathan, Roitburd-Berman, Anna, Siman-Tov, D Dror, Natalia T Freund, , Weiss, Yael
  • Pharmacological Chaperones in Nephrogenic Diabetes Insipidus: Possibilities for Clinical Application
    BioDrugs, Vol. 21, No. 3. (2007), pp. 157-166.
    by Robben, H Joris, Deen, MT Peter
  • Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma
    BioDrugs, Vol. 21, No. 3. (2007), pp. 167-177.
    by Rao, P Vasantha, Epstein, L David
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/adis-bio

    Result page: 1 2 3 4 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.